Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 26;2:6.
doi: 10.3978/j.issn.2306-9759.2015.03.01. eCollection 2015.

Mesenchymal Stem Cells as Delivery Vectors for Anti-Tumor Therapy

Affiliations
Free PMC article
Review

Mesenchymal Stem Cells as Delivery Vectors for Anti-Tumor Therapy

Zhenzhen Li et al. Stem Cell Investig. .
Free PMC article

Abstract

Recent studies have demonstrated mesenchymal stem cells (MSCs) are able to migrate specifically to tumors and their metastatic sites when administered intravenously. This characteristic tumor tropism has opened up an emerging field to utilize MSCs as vectors to deliver anti-cancer agents for targeted therapies. Genetically engineered MSCs can specifically migrate to various tumors and locally secrete therapeutic proteins, such as interferon β (IFN-β) and IFN-γ, interleukin 12 and 24, tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or suicide gene/enzyme prodrug. In addition, MSCs have also been engineered to deliver oncolytic viruses and drug-loaded nanoparticles. Here, we present the characteristics of MSCs, the current progress on MSC mediated anti-cancer agents delivery systems and the interaction between MSCs and tumors.

Keywords: Mesenchymal stem cell (MSC); cancer therapy; delivery vector.

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles
Feedback